Javascript must be enabled to continue!
The New Era of Three-Dimensional Annuloplasty Devices for Mitral Valve Repair: Rationale and First Experiences
View through CrossRef
Annuloplasty should always accompany mitral valve repair in order to achieve proper annular remodeling and stabilization. Numerous types of annuloplasty rings—that differ from rigid to semi-rigid and flexible devices, from complete to partial, and from flat to saddle-shaped rings—are clinically available. A deeper understanding of mitral valve function, in conjunction with several recent studies, suggest it is advisable to prefer annuloplasty rings that mimic the physiological mitral annulus shape and three-dimensional (3D) dynamic changes in order to reduce haemodynamic stress on valve components and optimize leaflet coaptation, perhaps improving valve repair durability too. This paper aims to focus on 3D annuloplasty rings, with dynamic features: MEMO 3D™ and MEMO 4D™ (Sorin Medical, New York, New York), as well as Physio Flex (Edwards Lifesciences, Irvine, California).
Surgical Technology Online
Title: The New Era of Three-Dimensional Annuloplasty Devices for Mitral Valve Repair: Rationale and First Experiences
Description:
Annuloplasty should always accompany mitral valve repair in order to achieve proper annular remodeling and stabilization.
Numerous types of annuloplasty rings—that differ from rigid to semi-rigid and flexible devices, from complete to partial, and from flat to saddle-shaped rings—are clinically available.
A deeper understanding of mitral valve function, in conjunction with several recent studies, suggest it is advisable to prefer annuloplasty rings that mimic the physiological mitral annulus shape and three-dimensional (3D) dynamic changes in order to reduce haemodynamic stress on valve components and optimize leaflet coaptation, perhaps improving valve repair durability too.
This paper aims to focus on 3D annuloplasty rings, with dynamic features: MEMO 3D™ and MEMO 4D™ (Sorin Medical, New York, New York), as well as Physio Flex (Edwards Lifesciences, Irvine, California).
Related Results
Midterm Results of Mitral Valve Repair for Atrial Functional Mitral Regurgitation: A Retrospective Study
Midterm Results of Mitral Valve Repair for Atrial Functional Mitral Regurgitation: A Retrospective Study
Abstract
Background: Annular dilation by left atrial remodeling is considered the main cause of atrial function mitral regurgitation. Although acceptable outcomes have been...
Recurrence of Mitral Valve Regurgitation After Mitral Valve Repair in Degenerative Valve Disease
Recurrence of Mitral Valve Regurgitation After Mitral Valve Repair in Degenerative Valve Disease
Background—
Durability assessment of mitral valve repair for degenerative valve incompetence is actually limited to reoperation as the primary indicator, w...
Ischemic mitral regurgitation: mitral valve replacement, restrictive annuloplasty or multi-component reconstruction with subvalvular intervention (systematic review and meta-analysis)
Ischemic mitral regurgitation: mitral valve replacement, restrictive annuloplasty or multi-component reconstruction with subvalvular intervention (systematic review and meta-analysis)
Objective: The study is aimed at assessing short- and long-term results of various strategies of surgical treatment in patients with ischemic mitral insufficiency.
Methods: The stu...
Transcatheter Edge-to-Edge Repair of the Mitral Valve in Four Dogs
Transcatheter Edge-to-Edge Repair of the Mitral Valve in Four Dogs
Mitral valve disease is a common heart disease in dogs. The aim of this study was to describe the cases of dogs who underwent mitral valve repair using a v-clamp device and to prov...
Transcatheter Edge-to-Edge Repair of the Mitral Valve in Four Dogs
Transcatheter Edge-to-Edge Repair of the Mitral Valve in Four Dogs
Mitral valve disease is a common heart disease in dogs. The aim of this study was to describe the cases of dogs who underwent mitral valve repair using a v-clamp device and to prov...
Modulation of Transforming Growth Factor-β Signaling and Extracellular Matrix Production in Myxomatous Mitral Valves by Angiotensin II Receptor Blockers
Modulation of Transforming Growth Factor-β Signaling and Extracellular Matrix Production in Myxomatous Mitral Valves by Angiotensin II Receptor Blockers
Background—
Little is known about the pathophysiology of myxomatous degeneration of the mitral valve, the pathological hallmark of mitral valve prolapse, associated wit...
Early results of mitral vavle repair of degenerative mitral valve regurgitation
Early results of mitral vavle repair of degenerative mitral valve regurgitation
Background: Mitral valve regurgitation due to degenerative valve disease is a common disease affecting about 2% of the population, mainly in developed countries [2],[6]. Medical t...
Transcatheter mitral valve-in-valve implantation: a 10-year single center experience
Transcatheter mitral valve-in-valve implantation: a 10-year single center experience
Abstract
Background
Transcatheter mitral valve-in-valve (TMVIV) appears a reasonable alternative to surgical redo mitral valve r...

